Company Overview of NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. develops vaccines to protect patients from fungal and bacterial infections. Its products include NDV-3, a vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by fungal and bacterial pathogens; and Als3, an antigen vaccine, which provides protection against systemic and mucosal candidal infections. NovaDigm Therapeutics, Inc. was founded in 2005 and is based in Grand Forks, North Dakota.
4201 James Ray Drive
REAC 1 Building
Grand Forks, ND 58202
Founded in 2005
Key Executives for NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Noevir Holding of America, Inc.||United States|
|Boehringer Ingelheim Corporation||United States|
|G & W Laboratories, Inc.||United States|
|Coquí RadioPharmaceuticals, Corp.||United States|
|Ablaris Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact NovaDigm Therapeutics, Inc., please visit www.novadigmtherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.